Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 42 43 44 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Sepiatec–Sobera Capital: investment, 201105 existent listed as portfolio company at web site 2011-05-20
Nycomed–Takeda: investment, 201105 acquisition €9.6b from private equity funds on cash + debt free basis announced 2011-05-19
Themis Bioscience–SEVERAL: investment, 201105 financing round Series A €5m co-led by Ventech + Crédit Agricole Private Equity 2011-05-18
Curetis–Akampion: public relations, 201105 service existent 2011-05-17
Curetis–SEVERAL: investment, 201105 financing round Series A extension additional €6m new investor CD-Venture + existing investors 2011-05-17
Analytisches Zentrum Biopharm–Agilent: mass spectrometer, 201105 supply existent Agilent 1100 MSD LC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Agilent: mass spectrometer, 201105 supply existent Agilent GC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Bruker Corp: mass spectrometer, 201105 supply existent Esquire 3000+ LC/MS system listed on web site 2011-05-15
Analytisches Zentrum Biopharm–Danaher: mass spectrometer, 201105 supply existent API 4000 LC/MS system listed on web site 2011-05-15
MYR GmbH–High-Tech Gründerfonds: investment, 201105 HTGF invests €500k 2011-05-12
Aperio–Definiens: image analysis s/w, 201105– collab co-marketing ww non-excl Definiens Tissue Studio with Aperio’s digital pathology solutions 2011-05-10
Klinikum Bayreuth–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system 2011-05-08
Université Catholique de Louvain–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system at Saint-Luc 2011-05-08
Vatican Hospital–Bruker Corp: mass spectrometer, 201105 supply existent MADLI Biotyper ID integrated w BD Phoenix system 2011-05-08
Epigenomics–Life Technologies: Dynabeads, 201105– supply Dynabeads MyOne SILANE for Epi proColon 2.0 by Invitrogen Dynal AS 2011-05-06
JnJ–Cenix BioScience: siRNA technology, 201105– collab + technology license agreem incl co-developm of DARE siRNA delivery techn Janssen Pharmaceutica 2011-05-04
Protectimmun–High-Tech Gründerfonds: investment, 201105 1st financing round totalling €1.3m incl HTGF + ELS-Fonds + KfW 2011-05-04
Protectimmun–SEVERAL: investment, 201105 1st financing round €1.3m investors HTGF + ELS-Fonds + KfW 2011-05-04
CCS Cell Culture Service–InSphero: cell culture technology, 201105– collab commercial incl product integration 2011-05-03
Delenex–SEVERAL: investment, 201105 financing round series A extension of addit CHF16.7m (€13m) lead + new investor Novo Ventures 2011-05-03
Transcatheter Technologies–High-Tech Gründerfonds: investment, 201105 financing round Series A totalling €1.7m incl returning co-investor HTGF 2011-05-03
Transcatheter Technologies–SEVERAL: investment, 201105 financing round Series A €1.7m lead investor Rolf Käse 2011-05-03
Evolva–Publicis: public relations, 201105 service existent by Capital MSL 2011-05-02
Dako–Tecan: Dako Omnis staining platform, 201105– supply OEM by Tecan 2011-05-01
Marine Fungi project–EU (govt): grant, 201105–201404 FP7 grant €3m 2011-05-01
Marine Fungi project–Evotec: drug discovery, 201105–201404 project partner for screening is European ScreeningPort GmbH 2011-05-01
Marine Fungi project–Leibniz-Gemeinschaft: drug discovery, 201105–201404 project partner + co-ordinator KiWiz Kieler Wirkstoffzentrum 2011-05-01
Co.don–SEVERAL: investment, 201104 capital increase €1.07m net €1m 1.07m new common shares €1/share 2011-04-29
Biocon–Axicorp: investment, 201104 management buy-out of 78% of Axicorp from Biocon for €40m 2011-04-28
Silence Therapeutics–SEVERAL: investment, 201104–201105 institutional placing + open offer £5.9m 275m+21.7m new ordinary shares 2p/share 2011-04-27
Evotec–ROI Verwaltungsgesellschaft: investment, 201104 existent ROI owns 17.4m voting rights or 15.07% of voting rights 2011-04-20
Protagen–Scienion: protein microarrays, 201104– service supply of protein microarray batches to Protagen using sciFLEXARRAYER 2011-04-19
Scienion–Protagen: print/spotting technology, 201104– collab co-developm proteomic applications of sciFLEXARRAYER technology for diagnostics + pharma 2011-04-19
Bayer–Max Planck: cancer drug, 201104– license ww excl to lead structure from Lead Discovery Center €na upfront + up to 137.5m milestones + royalties 2011-04-18
Integrated Diagnostics–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Novartis–Biognosys: proteomic services, 201104– supply service Targeted Proteomics techn for undisclosed discovery area of Novartis Vaccines Siena 2011-04-18
Pfizer–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Philips–Biognosys: proteomic services, <=201104 supply service using Targeted Proteomics technolgoy to identify + quantify proteins 2011-04-18
Danaher–Definiens: image analysis s/w, 201104– collab co-marketing Definiens XD s/w with Leica microscopy hardware 2011-04-14
Jacobs Univ–Roche: xCELLigence system, 201104– supply existent used by Brix group in School of Engineering and Science 2011-04-14
F-Star–SEVERAL: investment, 201104 financing round €15m lead investor SR One + investments by all existing investors 2011-04-13
Daiichi Sankyo–Pieris: Anticalin scaffold technology, 201104– collab €7m upfront + up to €200m + royalties drug discovery Anticalins for 2 targets 2011-04-12
Abunda Nutrition–Evolva: investment, 201104– acquisition merger announced for 25m shares = 12.9% post transaction, fully diluted 2011-04-05
Cellestis–Qiagen: investment, 201104–201108 acquisition $374m 2011-04-04
Corning–Eppendorf: gradient PCR technology, 201104 license to Labnet International incl US Patents 6767512 + 7074367 2011-04-04
Roche–Eppendorf: gradient PCR technology, 201104 license to F Hoffman-La Roche Ltd incl US Patents 6767512 + 7074367 2011-04-04
Beun-de Ronde–SAW Instruments: acoustic biosensor, 201104– distribution of sam biosensors in NL by Beun-de Ronde BV 2011-04-01
Bruker Corp–Germany (govt): grant, 201104–201403 grant €409k to Bruker Daltonik GmbH in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
eADMET–SEVERAL: investment, 201104c seed financing round from High-Tech Gründerfonds + Bayern Kapital 2011-04-01
Fraunhofer–Germany (govt): grant, 201104–201403 grant €287k to Fraunhofer MEVIS in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
Univ Bremen–Germany (govt): grant, 201104–201403 grant €226k to Zentrum für Technomathematik in MALDI-AMK 3D MALDI Imaging project from BMBF 2011-04-01
Acacia Pharma–Gilde Investment: investment, 201103 financing round Series A totalling $10m incl existing investor Gilde Healthcare 2011-03-31
Acacia Pharma–Lundbeck: investment, 201103 financing round Series A totalling $10m incl new investor Lundbeckfond Ventures 2011-03-31
Acacia Pharma–SEVERAL: investment, 201103 financing round Series A $10m from new investor Lundbeckfond Ventures + existing investor Gilde Healthcare 2011-03-31
Advanced Cell Diagnostics–Definiens: image analysis s/w, 201103– collab developm biomarker analysis solutions build on RNAscope platform 2011-03-31
BioVersys–SEVERAL: investment, 201103 seed financing round CHF2.5m led by EVA + joined by private investors out of BioBAC 2011-03-31
Definiens–Ricochet Public Relations: public relations, 201103 service existent 2011-03-31
General Electric–Ricochet Public Relations: public relations, 201103 service existent for GE Healthcare 2011-03-31
Newron–Merck (DE): CNS drugs, 201103– developm license €na for pruvanserin + sarizotan from Merck Serono with buy-back option for Merck Serono 2011-03-31
Sigma-Aldrich–Ricochet Public Relations: public relations, 201103 service existent 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent apex ultra Qh-FTMS at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent esquire 6000 ion trap at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent maXis UHR-TOF at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent two HCT ultra ETD II ion traps at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Bruker Corp: mass spectrometer, 201103 supply existent ultraflex III MALDI-TOF/TOF at Centre of Excellence in Mass Spectrometry 2011-03-31
Univ York–Danaher: mass spectrometer, 201103 supply existent API QSTAR Pulsar i ES-Q-o-TOF MS w oMALDI at Thomas-Oates group 2011-03-31
Univ York–Thermo Fisher: mass spectrometer, 201103 supply existent Thermo Finnigan LCQ Deca XP plus ES-QIT w Surveyor HPLC at Thomas-Oates group 2011-03-31
Essex Scientific–Hamilton: laboratory equipment + instruments, 201103 distribution existent ESSLAB is key distributor incl service in UK 2011-03-29
aCROnordic–Manipal: investment, 201103–2012 acquisition of aCROnordic A/S by Ecron Acunova GmbH 2011-03-28
Anergis–SEVERAL: investment, 201103 financing round Series A CHF18m led by Vinci Capital + BioMedInest + Sunstone Capital 2011-03-28
Moldiax–Analytik Jena: investment, 201103 acquisition 23.5% share by Analytik Jena AG 2011-03-24
Nimbus Discovery–Proteros: drug discovery services, 201103– supply service delivery of X-ray protein crystal structures for multiple targets 2011-03-23
AMSilk–SEVERAL: investment, 201103 financing round Series B €5m incl investors MIG Fonds + AT Newtec 2011-03-17
Seegene–Kompass: MolYsis technology, 201103– collab Seegene Magicplex Sepsis test is based on Molzym MolYsis and Nordiag's Arrow system 2011-03-17
MorphoSys–Boehringer: biopharmaceutical contract manufacturing, 201103– supply service process develop + manufacturing for MOR208 program 2011-03-16
Instraction–Protagen: protein separation, 201103– collab developm customised instAction Phases for downstream processing of biotherapeutics 2011-03-15
PVT Probenverteiltechnik–Roche: investment, 201103 acquisition €65m upfront + up to €20m milestones 2011-03-15
Takeda–Evotec: mass spectrometry services, 201103– collab Kinaxo will apply PhosphoScout techn to assist drug developm research of Takeda 2011-03-15
GNA Biosolutions–PERSON: investment, 201103 1st financing round €na capital increase by private investor from Munich 2011-03-14
NovaShunt–SEVERAL: investment, 201103 financing round Series B CHF23.7m=$25m 2011-03-09
Avacta–V&F: mass spectrometer, 201103 distribution of IMR-MS systems + services in UK + IRL by Oxford Molecular Diagnostics 2011-03-07
Biomat-IN project–BioRegio STERN: biomaterials, 201103–201402 collab BioRegio STERN is project partner 2011-03-01
Biomat-IN project–EU (govt): grant, 201103–201402 support €1.24m from ERDF under Interreg IVB North West Europe 2011-03-01
BioRegio STERN–EU (govt): grant, 201103–201402 ERDF support €1223k as partner in Biomat-IN EU project 2011-03-01
Life Sciences Bremen–Bionsys: life sciences, 201103– membership Bionsys joins LSB 2011-03-01
Theragenics–Eckert & Ziegler: investment, 201103–201104 unfriendly takeover offer $2.2/share NOT REALISED 2011-03-01
Qiagen–Epigenomics: DNA methylation analysis, 201102– license option ww non-excl to SEPT9 biomarker + DNA methylation technologies (LT) 2011-02-28
Applikon–Automation Partnership: laboratory equipment, 201102– distribution of ambr™ + Fill-It™ in Benelux by Applikon 2011-02-24
Michrom–Bruker Corp: investment, 201102–201104 acquisition €na 2011-02-24
NEU² project–Biotest: MS drug RnD, 201102– collab Biotest AG becomes project member for clinical developm of BT-061 in MS 2011-02-24
Biofrontera–SEVERAL: investment, 201102 private placement capital increase €1.8m 880k new shares 2011-02-22
Euroimmun–Scienion: print/spotting technology, 201102 supply sciFLEXARRAYER for r+d + production purposes of microarray diagnostic products 2011-02-21
Max Planck–Proteros: drug discovery services, 201102– supply preferred service partner to support kinase drug discovery research 2011-02-21
Süd-Chemie–Clariant: investment, 201102–201111 acquisition €2b in cash + shares 2011-02-16
Evotec–ChemBridge: chemical compound libraries, 201102– supply €na access to initially 110k compounds from ChemBridge Library Collection 2011-02-15
Chemagen–PerkinElmer: investment, 201102 acquisition 2011-02-14
Kinaxo–Evotec: investment, 201102–201104 acquisition €12m upfront with €3m in cash + 2.6m shares plus up to €4m cash milestones 2011-02-09
Danaher–GeneBio: bioinformatics, 201102– collab co-marketing SmileMS with AB Sciex mass spectrometers 2011-02-08
Beckman Coulter–Danaher: investment, 201102–201106 acquisition cash tender offer $6.8b $83.5/share 2011-02-07
Activaero–SEVERAL: investment, 201102 financing round €5m led by LSP Life Sciences Partners with €3.5m 2011-02-02
next pagenext page 1 2 3 ... 42 43 44 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top